Hypoglycemic agent 3

• Target :

  Akt|||NF-?B|||PI3K

• Related Pathways :

  Cytoskeletal Signaling|||PI3K/Akt/mTOR signaling|||NF-?B

• Bioactivity :

  Compound H26, a derivative of corosolic acid, functions as Hypoglycemic agent 3. It exhibits lipid-lowering and significant blood glucose-reducing properties, making it a potential hypoglycemic drug. Hypoglycemic agent 3 targets MCCC1 to mitigate insulin resistance, and may be useful in researching type 2 diabetes.

• Smiles :

  C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CCC4[C@]3(CCC5[C@@]4(C[C@H]([C@@H](C5(C)C)O)O)C)C)[C@@H]2[C@H]1C)C)C(=O)NCC(=O)O

• Molecular Formula :

  C32H51NO5

• Molecular Weight :

  529.751

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C